Levaxela solution for infusions 5 mg/ml. 100 ml. №1 vial


Manufacturer: Slovenia

Infections caused by sensitive to the medication microorganisms: non-hospital pneumonia; complicated skin and soft tissue infections; complicated urinary tract infections (including pyelonephritis); chronic bacterial prostatitis; pulmonary form of anthrax: prevention after contact and treatment.



Levaxela solution Composition:
active substance: levofloxacin;

1 ml of 5 mg levofloxacin in the form of levofloxacin hemihydrate;

excipients: sodium chloride, concentrated hydrochloric acid, water for injection.

Levaxela solution Indications.
Infections caused by microorganisms sensitive to the drug:

community-acquired pneumonia
complicated infections of the skin and soft tissues;
complicated urinary tract infections (including pyelonephritis);
chronic bacterial prostatitis
pulmonary anthrax: prevention after exposure and treatment.

Levaxela solution Contraindications
Hypersensitivity to levofloxacin, other fluoroquinolones, or any ingredient in the drug
tendon damage associated with the use of fluoroquinolones;
pregnancy and lactation.

Levaxela solution Method of administration and dosage.
Levaxel® infusion solution is administered slowly once or twice a day. The dosage depends on the type and severity of the infection, as well as the susceptibility to the drug of the possible pathogen. Treatment with Levaxel® after the initial use of its intravenous form can be completed with the oral form, provided that such treatment is acceptable for a particular patient. Given the bioequivalence of parenteral and oral dosage forms, you can use the same dose.

Mode of application

Levaxel® infusion solution is intended for slow administration only; it is prescribed 1 or 2 times a day. The duration of the infusion should be at least 30 minutes for 250 mg or 60 minutes for 500 mg solution (see Section “Peculiarities of use”).

The issue of incompatibility is discussed in the section “Incompatibility”, compatibility with other infusion solutions – in the section “Special safety measures”.

Levofloxacin is contraindicated in children (under the age of 18), since damage to the articular cartilage is possible.